Croda International PLC
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
GBX 1,288.00 | Zygjkyq | Mlqjhmpfk |
Croda's Well-Positioned Drug Delivery Portfolio Should Drive Strong Growth
Business Strategy and Outlook
Croda is a British specialty chemicals company focused on the consumer, crop protection, and healthcare end markets. Croda targets fast-growing niches across these industries, looking to consolidate its presence by acquiring early-stage technology and science-rich firms and becoming entrenched in the supply chain of its customers through its high-touch direct selling model and a strong focus on collaborative innovation. A key driver for the company is the percentage of sales from new and protected products, or NPPs, which represented around 35% of group sales in 2022.